0001415889-24-000817.txt : 20240108 0001415889-24-000817.hdr.sgml : 20240108 20240108175012 ACCESSION NUMBER: 0001415889-24-000817 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240105 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brockstedt Dirk G. CENTRAL INDEX KEY: 0001635616 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 24521267 MAIL ADDRESS: STREET 1: C/O ADURO BIOTECH, INC. STREET 2: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 form4-01082024_100105.xml X0508 4 2024-01-05 0001673772 RAPT Therapeutics, Inc. RAPT 0001635616 Brockstedt Dirk G. C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false CHIEF SCIENTIFIC OFFICER 0 Common Stock 2024-01-05 4 S 0 898 22.78 D 27820 D These shares were sold solely to pay taxes due upon vesting of the Restricted Stock Units granted on January 30, 2020 for 8,000 shares. Includes 1,646 shares and two shares acquired by Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on April 28, 2023 and October 31, 2023, respectively. /s/ Rodney Young, Attorney-in-Fact 2024-01-08